DiviDrip · ZVRA

ZVRA — Zevra Therapeutics, Inc. Common Stock

ZVRA is Zevra Therapeutics, Inc. Common Stock (Healthcare) — a non-dividend-paying stock. Trading at $12.40. Market cap: $745M. Capital Quality Rank: 51/100 — Above average.

Stock snapshot

Price$12.40
Market cap$745M
SectorHealthcare
ExchangeXNAS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)51 / 100 · Above average
ROIC (TTM)-32.3%
Shareholder buyback yield-19.23%
Altman Z-score zoneDistress

About ZVRA

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Listed2015Employees61HQBoston, MASectorHealthcareWebsitezevra.com

Related non-dividend companies

Other non-dividend stocks investors research alongside ZVRA. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is ZVRA's current stock price?

ZVRA (Zevra Therapeutics, Inc. Common Stock) is currently trading at $12.40.

Does ZVRA pay a dividend?

ZVRA (Zevra Therapeutics, Inc. Common Stock) does not currently pay a regular dividend.

What is ZVRA's Capital Quality Rank?

ZVRA has a Capital Quality Rank of 51/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track ZVRA in DiviDrip

Add ZVRA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow